Study of 611 for moderate to severe COPD in adults
Part of Lungs & breathing clinical trials.
This trial tests a new medicine called 611 for people with moderate to severe COPD. It aims to see if adding 611 to your current treatments can help prevent flare-ups and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 85 years old.
- You are a current or former smoker with at least a 10 pack-year smoking history (for example, smoking 1 pack a day for 10 years).
- You have been diagnosed with COPD for at least 12 months and have moderate to severe disease.
- You have had at least 2 moderate or 1 severe COPD flare-up in the past year.
- You have been on triple therapy (ICS + LABA + LAMA) for at least 3 months, or double therapy (LABA + LAMA) if you cannot take ICS.
- You do not have asthma, another lung condition, or active infections like hepatitis or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
This trial tests a new medicine called CM326 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve lung function.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This study tests a new medication called CM310 for people with moderate to severe COPD who have frequent flare-ups and a certain type of inflammation. The goal is to see if CM310 can reduce these flare-ups and improve breathing.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
Hear when a new Pulmonary Disease, Chronic Obstructive (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.